Purdue Ends OxyContin Patent Suit With $62M Payout
Purdue Pharma LP has agreed to pay Assertio Therapeutics Inc., formerly known as Depomed Inc., $62 million in cash to settle claims in New Jersey federal court that Purdue's blockbuster opioid...To view the full article, register now.
Already a subscriber? Click here to view full article